Are oral OSA medications a real threat to CPAP providers who have dedicated a lot of time and money to serving patients?

Medtrade exhibitor Inogen revealed second quarter revenue of $92.3 million, a year-over-year increase of 4.0%.

Medtrade exhibitor Resmed Inc. revealed a revenue increase of 10% to $1.3 billion for fourth quarter 2025.

Medtrade exhibitor Inogen has appointed Kevin P. Smith as general counsel and executive vice president.

Second quarter results for Medtrade exhibitor Philips yielded group sales of EUR $4.3 billion.

Total operating revenue was a record $2.02 billion, an increase of 16% from the prior financial year.